Gilles De Meester

Mr. Gilles De Meester

UGent

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
MSMieke Steenbeke
Mieke Steenbeke
SBSander De Bruyne
Sander De Bruyne
EAElisabeth Van Aken
Elisabeth Van Aken
Griet GlorieuxGriet Glorieux
Griet Glorieux
WBWim Van Biesen
Wim Van Biesen
Joris DelangheJoris Delanghe
Joris Delanghe
Advanced glycation end products (AGEs) are a class of proteins or lipids that are non-enzymatically glycated and oxidized after contact with aldose sugars. The accumulation of AGEs results in carbonyl stress, which is characteristic for diabetes mellitus, uremia, atherosclerosis and vascular dysfunction. In recent decades, several innovative methods have been developed to measure the concentration of AGEs in blood or urine. In the present study, we evaluated the use of UV fluorescence as an alternative tool to detect urinary AGEs in four groups of well characterized chronic kidney disease (CKD) patients over a wide range of kidney insufficiency and in a group of healthy subjects. Using an excitation wavelength of 365 nm, the fluorescence spectra of urinary AGEs were recorded in the 400–620 nm emission range. When considering the emission peaks at 440 nm and 490 nm, a significantly higher AGE-specific fluorescence intensity was detected in CKD patients compared to healthy subjects (p < 0.0001 and p = 0.0001, respectively). The urinary creatinine adjusted fluorescence emission spectra in the group of CKD patients with diabetes mellitus were comparable with those of CKD patients without diabetes mellitus. Creatinine-adjusted fluorescence emission spectra were highest in CKD patients with proteinuria, moderate in CKD patients without proteinuria and lowest in healthy controls (p < 0.0001 at both emission wavelengths). In a multiple regression analysis, age, CRP and insulin treatment were predictors of fluorescence intensity at the emission wavelength of 440 nm. Age and insulin treatment were predictors at 490 nm. The presented method is a simple, cheap, alternative method to monitor the AGE-load in the CKD population.

12 May 2026 in Virulence
Verified
Journal Article
Open access
MWMerel Wauters
Merel Wauters
LBLaura Bollé
Laura Bollé
GMGilles De Meester
Gilles De Meester
SBSara Van Den Bossche
Sara Van Den Bossche
LGLucia Grassi
Lucia Grassi
ACAurélie Crabbé
Aurélie Crabbé
Chronic infection with Pseudomonas aeruginosa is a major driver of airway inflammation, which plays a central role in the progression of cystic fibrosis (CF) lung disease. During long-term colonization, P. aeruginosa adapts to the CF lung by downregulating virulence factors and adopting a biofilm-associated, mucoid lifestyle. Despite the expected reduction in immune activation due to these adaptations, excessive inflammation persists, a paradox that remains poorly understood. Our objective was to identify novel bacterial mediators sustaining persistent inflammation by P. aeruginosa in the CF lung. To this end, we analyzed clinical P. aeruginosa CF isolates, cultured them in synthetic CF sputum medium, and exposed 3D lung epithelial cell cultures to the resulting cell-free supernatants. There was considerable variability in pro-inflammatory activity among the isolates, with a subset of the isolates inducing strong IL-8 secretion by the 3D cells despite low production of known virulence factors. Comparative proteomics analysis of the cell-free supernatants of pro-inflammatory and immunosuppressive isolates revealed several mediators not previously linked to inflammation. Thirteen of these candidate pro-inflammatory mediators were selected for further analysis. Using P. aeruginosa transposon mutants lacking the respective mediators, DksA (a transcription factor) was confirmed as an immunomodulatory mediator in the 3D lung model. Finally, analysis of existing transcriptomes of P. aeruginosa in CF sputum revealed that dksA was found to be one of the most strongly expressed genes in this patient population, highlighting the relevance of our findings. In conclusion, we identified a novel P. aeruginosa mediator that may contribute to CF airway inflammation.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
GMGilles De Meester
Gilles De Meester
MWMerel Wauters
Merel Wauters
LFLukas Fabri
Lukas Fabri
TCTom Coenye
Tom Coenye
ACAurélie Crabbé
Aurélie Crabbé
Introduction: Short-chain fatty acids (SCFAs) are found in higher concentrations in the airways of COPD patients compared to healthy controls. However, the role of these SCFAs in the pathophysiology of COPD remains unclear. Therefore, this study aims to evaluate the impact of SCFAs on both human lung epithelial cells, and bacterial pathogens that are frequently associated with acute COPD exacerbations. Methods: 3 SCFAs were included in this study: acetate, propionate and butyrate. Their impact on the activity of 4 relevant antibiotics was evaluated in biofilm inhibition experiments with Moraxella catarrhalis DSM 11994. The most interesting findings were validated with 2 additional strains. The effects of SCFAs on host cells were investigated using an in vivo-like 3-D lung epithelial cell model. Cytotoxicity was assessed by measuring LDH release and through microscopic evaluation, and immunomodulation was evaluated by quantifying the secretion of pro-inflammatory interleukin-8 (IL-8) via ELISA. Results: The effect of SCFAs on antibiotic activity depended on the used antibiotic, SCFA type and concentration, and bacterial strain. Interestingly, propionate attenuated the biofilm-inhibiting activity of doxycycline for all 3 strains of M. catarrhalis. Propionate and butyrate were cytotoxic to 3-D lung cells at high concentrations, whereas acetate was not. In addition, all 3 SCFAs showed a pro-inflammatory effect by stimulating IL-8 secretion in 3-D lung epithelial cells. Conclusion: SCFAs may influence the pathophysiology of COPD by decreasing doxycycline activity against pathogens and by exerting cytotoxic and pro-inflammatory effects towards host cells.